Statistically significant and clinically meaningful progression-free survival (PFS) and overall survival (OS) data for Zepzelca ® (lurbinectedin) and atezolizumab (Tecentriq ®) combination underscore ...
Shares of Jazz Pharmaceuticals JAZZ rose nearly 21% on Monday after it announced positive top-line results from the late-stage HERIZON-GEA-01 study. This study evaluated different combination regimens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results